Companies · Healthtech

Wildflower Health, Inc.

SAN FRANCISCO · Healthtech · refined from filed group “Other Technology

Diligence memoA one-page analyst read on Wildflower Health, Inc. — recommendation, valuation, rhythm, risks.
$19.6M
Total raised · real
2
Rounds
10.5×
Latest step-up
Top 21%
Sector rank · raised
Series B
Latest stage · inferred · Wed Nov 27 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

Wildflower Health, Inc. looks under-valued against its niche peers and is quiet on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the healthtech sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.65× the median modeled value of Series B Healthtech companies in 2022–2024 (98 peers) — value vs value, same stage and era.
Quiet
  • Last raise 19 mo ago; this sector typically re-raises about every 14 months.
  • Slightly overdue versus sector cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Healthtech

Wildflower Health, Inc. is one of 2138 Healthtech companies tracked from SAN FRANCISCO. By capital raised it ranks in the upper tier (ahead of 80% of sector peers), and in the upper tier by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
12
Investors (latest)
2024-11-27
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$50M$100M$150M$200MSeed · 2013-11-22 Raised $1.7M (real) Modeled valuation $47M (est)$1.7M$47MSeed2013Series B · 2024-11-27 Raised $18M (real) Modeled valuation $107M (est)$18M$107MSeries B2024+$18MCumulative $20M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Seed$1.7M · 2013
Series B$17.9M · 2024no Series A on file

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Series A — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 50%.

Modeled valuation trajectory
$106.7M
Base estimate est.
$42.2M
Conservative case
$176.7M
Upside case
$99.7M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Ba $15M–$40M round). Valuation is modeled from stage benchmarks scaled by the healthtech sector profile. Directional, not a quoted figure.

Seed · modeled $47.3M · 2013-11-222013Series B · modeled $106.7M · 2024-11-272024
Model inputs · modeled:benchmark-stage-stepup-v1
18%
Dilution assumption
Implied ownership sold in the financing.
64%
Survival probability
42% low · 78% high
1.38×/yr
Annual markup
1.67×/yr upside case
1.6 yr
Elapsed time used
1.6 yr actual, capped for stale marks
healthtech
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
132 mo
Avg between rounds
$1.8M/yr
Capital velocity
12.6 yr
On record since
2013
First round
2
Rounds on file
How it compares to the market

Benchmarked against 2138 companies in Healthtech. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 4.4× above median
This company$19.6M
Sector median$4.5M
Latest round — vs other Series B rounds in sector (real $, this stage) 1.0× of median
This company$17.9M
Sector median$18.3M
Modeled value — vs sector median (estimate, all stages) 3.2× above median
This company$106.7M
Sector median$33.8M

Raised more than 80% of sector peers (real $). Modeled value above 77% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series B) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #72 of 98.

This companyCohort peer
$10.0M$100.0M$1.0B$10.0M$100.0MCapital raised (log)Casana Care, Inc. · Series B Raised $56.4M · modeled $608.0M (est)Mendel Health Inc. · Series B Raised $52.7M · modeled $570.9M (est)Bicycle Health Inc. · Series B Raised $61.4M · modeled $492.6M (est)Brave Health, Inc. · Series B Raised $38.6M · modeled $485.7M (est)Flume Health, Inc. · Series B Raised $35.9M · modeled $446.0M (est)Healthy America, LLC · Series B Raised $31.0M · modeled $435.9M (est)Moxe Health Corp · Series B Raised $34.8M · modeled $404.2M (est)Kintsugi Mindful Wellness, Inc. · Series B Raised $25.0M · modeled $370.4M (est)Invoq Health, Inc. · Series B Raised $41.5M · modeled $362.5M (est)Folx Health, Inc. · Series B Raised $59.3M · modeled $355.7M (est)Recuro Health, Inc. · Series B Raised $44.2M · modeled $340.0M (est)Orchard Healthcare, Inc. · Series B Raised $34.8M · modeled $338.9M (est)Wildflower Health, Inc. (this company) Raised $19.6M · modeled $106.7M (est)Wildflower Health, Inc.
CompanyStageRaised · realValue · estvs peer med.
Casana Care, Inc.Series B$56.4M$608.0M3.68×
Mendel Health Inc.Series B$52.7M$570.9M3.45×
Bicycle Health Inc.Series B$61.4M$492.6M2.98×
Brave Health, Inc.Series B$38.6M$485.7M2.94×
Flume Health, Inc.Series B$35.9M$446.0M2.70×
Healthy America, LLCSeries B$31.0M$435.9M2.64×
Moxe Health CorpSeries B$34.8M$404.2M2.45×
Kintsugi Mindful Wellness, Inc.Series B$25.0M$370.4M2.24×
Invoq Health, Inc.Series B$41.5M$362.5M2.19×
Folx Health, Inc.Series B$59.3M$355.7M2.15×
Recuro Health, Inc.Series B$44.2M$340.0M2.06×
Orchard Healthcare, Inc.Series B$34.8M$338.9M2.05×
Wildflower Health, Inc. this companySeries B$19.6M$106.7M0.65×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Seed$1.7M2013-11-22$8.5M$47.3M85%
Series B$17.9M2024-11-27$99.7M$106.7M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Seed$1.7M2013-11-22
    • First recorded raise — entered as Seed.
    • 19 investors on this round.
  2. Series B$17.9M2024-11-27
    • Raised again after 132 mo — slower than the ~14 mo sector norm.
    • Round 10.5× larger than the prior — scaling up.
    • 12 investors on this round.
Intelligence
2035 ~Q4
Modeled next raise · ~132mo cadence
$53.8M
Modeled next size est.range $35.0M$86.1M
10.5×
Last step-up
$1.8M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
John Crumpler6 other2024-11
Dawn Owens3 other2024-11
Ezra Mehlman3 other2024-11
Dan Galles2 other2024-11
Ralph Sabin2 other2024-11
Steven Lefar2 other2024-11
Katherine Bellevin2013-11
Kim Russell2024-11
Leah Sparks2013-11
Registry & provenance

Wildflower Health, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1593748
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Pyx Health Holdings, LlcHealthtechSeries B$28.1M$260.8Mnetwork1 shared operator · same sector · same stage
Elligo Health Research, Inc.HealthtechSeries B$41.5M$495.7Mnetwork1 shared operator · same sector · same stage
Aware Recovery Care, Inc.HealthtechSeries B$62.9M$31.3Mnetwork1 shared operator · same sector · same stage
Providence Dental Partners LLCHealthtechSeries B$19.2M$156.1Msame sector · same stage
Adagio Medical Holdings, Inc.HealthtechSeries B$19.0M$84.8Msame sector · same stage
Reema Health Inc.HealthtechSeries B$18.9M$93.1Msame sector · same stage
Relentless Health Inc.HealthtechSeries B$20.7M$107.4Msame sector · same stage
Panda Health, Inc.HealthtechSeries B$18.4M$109.1Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Seed Health, Inc.HealthtechSeries C$841.3M86%
TrueGen Health, Inc.HealthtechPre-Seed$1.5M84%
HedgeHog Health Inc.HealthtechPre-Seed$10.2M84%
Hazel Health, Inc.HealthtechSeries C$817.6M84%
Health Catalyst, Inc.HealthtechSeries C$323.6M83%
Courier Health, Inc.HealthtechSeed$68.3M83%
Shadow Health, Inc.HealthtechSeed$83.2M83%
Blackbird Health, Inc.HealthtechSeries B$176.9M83%
Frequently asked
How much funding has Wildflower Health, Inc. raised?
Wildflower Health, Inc. has raised approximately $19.6M in disclosed capital across 2 recorded financing rounds, aggregated from public filings.
What is Wildflower Health, Inc.'s estimated valuation?
Provath's modeled valuation for Wildflower Health, Inc. is approximately $106.7M (modeled range $42.2M–$176.7M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Wildflower Health, Inc. at?
Wildflower Health, Inc.'s latest modeled financing stage is Series B. Its most recent recorded round closed around Wed Nov 27.
What does Wildflower Health, Inc. do and where is it based?
Wildflower Health, Inc. operates in the Healthtech sector, based in SAN FRANCISCO.
Explore related

See where Wildflower Health, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Wildflower Health, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.